Pfizers

Sopa Images | Lightrocket | Getty ImagesPfizer's twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences. The drugmaker on…

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022.Wolfgang Rattay | ReutersThe National Institutes of Health said Monday it launched…

A tornado caused extensive damage to a Pfizer drug manufacturing site in Rocky Mount, N.C., on Wednesday, threatening critical supplies for hospitals across the country.The company estimated that one-fourth of the injectable medications it…

…

The US Food and Drug Administration on Wednesday (May 31) approved Pfizer's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.The…

Why It Matters: Older Adults Are at Higher Risk.Each year, about 60,000 adults 65 and older are hospitalized with R.S.V. and about 6,000 to 10,000 die from the virus, the F.D.A. estimated. The Centers for Disease Control and Prevention…

A Pfizer vaccine that could protect unborn babies from the common seasonal bug respiratory syncytial virus (RSV) has been recommended for approval by advisors to the Food and Drug Administration.The agency's expert panel voted unanimously…

Respiratory syncytial virus - viral vaccine under researchHailshadow | Istock | Getty ImagesThe Food and Drug Administration's independent panel of advisors on Thursday recommended full approval of Pfizer's vaccine that protects infants…

Fears were raised today that a Pfizer vaccine given to mothers-to-be could raise the risk of babies being born prematurely.Experts have called for tougher scrutiny over the new respiratory syncytial virus (RSV) jab, which could be approved…

Pfizer's experimental respiratory syncytial virus (RSV) vaccine was 82 per cent effective in preventing severe infections in infants when given to expecting mothers in the second half of their pregnancy, according to trial details published…